Skip to content

Study · Animal study (in vivo) · rat · 1984

6 results

Feeding, drinking, urine osmolality in DI Brattleboro rats: changes by morphine, naloxone, D-amino acids, prolyl-leucyl-glycinamide (PLG).

Koyuncuoğlu H, Berkman K, Sabuncu H

Pharmacology, biochemistry, and behavior1 Jan 1984Cited by 16 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study6

5 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In Brattleboro rats, PLG alone significantly decreased food intake.

    In plain wordsIn rats, PLG alone decreased food intake.

    Outcome
    DecreaseFood intake
    Study

    ratn: not reported in source

    Brattleboro rats
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated · 7 hoursAs given in this study (rat).

    Source sentences

    Summary
    Mor, Nal, D-Asp and PLG alone caused a significant decrease in food and fluid intake, urine volume and faeces weight and a significant increase in urinary osmolality being the osmolality of the Mor, D-Asp and PLG injected groups higher than 300 mOsmol/kg.
    2 context sentences
    Summary · context
    Brattleboro rats placed in metabolism cages were injected with morphine (Mor), naloxone (Nal), D- and L-aspartic acid (D- and L-Asp), D-phenylalanine (D-Phe), D-leucine (D-Leu) and prolyl-leucyl-glycinamide (PLG), alone and in suitable combinations.
    Summary · context
    Food and fluid intake, urine outflow, faeces weight, rectal temperature and urinary osmolality were determined at the end of seven hours period of time.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In Brattleboro rats, PLG alone significantly decreased fluid intake.

    In plain wordsIn rats, PLG alone decreased fluid intake.

    Outcome
    DecreaseFluid intake
    Study

    ratn: not reported in source

    Brattleboro rats
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated · 7 hoursAs given in this study (rat).

    Source sentences

    Summary
    Mor, Nal, D-Asp and PLG alone caused a significant decrease in food and fluid intake, urine volume and faeces weight and a significant increase in urinary osmolality being the osmolality of the Mor, D-Asp and PLG injected groups higher than 300 mOsmol/kg.
    2 context sentences
    Summary · context
    Brattleboro rats placed in metabolism cages were injected with morphine (Mor), naloxone (Nal), D- and L-aspartic acid (D- and L-Asp), D-phenylalanine (D-Phe), D-leucine (D-Leu) and prolyl-leucyl-glycinamide (PLG), alone and in suitable combinations.
    Summary · context
    Food and fluid intake, urine outflow, faeces weight, rectal temperature and urinary osmolality were determined at the end of seven hours period of time.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In Brattleboro rats, PLG alone significantly decreased urine volume.

    In plain wordsIn rats, PLG alone decreased urine volume.

    Outcome
    DecreaseUrine volume
    Study

    ratn: not reported in source

    Brattleboro rats
    Outcome group
    Kidney function · Kidney and urinary
    Studied dose
    Dose not stated · 7 hoursAs given in this study (rat).

    Source sentences

    Summary
    Mor, Nal, D-Asp and PLG alone caused a significant decrease in food and fluid intake, urine volume and faeces weight and a significant increase in urinary osmolality being the osmolality of the Mor, D-Asp and PLG injected groups higher than 300 mOsmol/kg.
    2 context sentences
    Summary · context
    Brattleboro rats placed in metabolism cages were injected with morphine (Mor), naloxone (Nal), D- and L-aspartic acid (D- and L-Asp), D-phenylalanine (D-Phe), D-leucine (D-Leu) and prolyl-leucyl-glycinamide (PLG), alone and in suitable combinations.
    Summary · context
    Food and fluid intake, urine outflow, faeces weight, rectal temperature and urinary osmolality were determined at the end of seven hours period of time.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In Brattleboro rats, PLG alone significantly decreased faeces weight.

    In plain wordsIn rats, PLG alone decreased faeces weight.

    Outcome
    DecreaseFaeces weight
    Study

    ratn: not reported in source

    Brattleboro rats
    Outcome group
    Gastrointestinal function · Gastrointestinal
    Studied dose
    Dose not stated · 7 hoursAs given in this study (rat).

    Source sentences

    Summary
    Mor, Nal, D-Asp and PLG alone caused a significant decrease in food and fluid intake, urine volume and faeces weight and a significant increase in urinary osmolality being the osmolality of the Mor, D-Asp and PLG injected groups higher than 300 mOsmol/kg.
    2 context sentences
    Summary · context
    Brattleboro rats placed in metabolism cages were injected with morphine (Mor), naloxone (Nal), D- and L-aspartic acid (D- and L-Asp), D-phenylalanine (D-Phe), D-leucine (D-Leu) and prolyl-leucyl-glycinamide (PLG), alone and in suitable combinations.
    Summary · context
    Food and fluid intake, urine outflow, faeces weight, rectal temperature and urinary osmolality were determined at the end of seven hours period of time.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In Brattleboro rats, PLG alone significantly increased urinary osmolality to above 300 mOsmol/kg.

    In plain wordsIn rats, PLG alone increased urine concentration.

    Outcome
    IncreaseUrinary osmolality
    Study

    ratn: not reported in source

    Brattleboro rats
    Outcome group
    Kidney function · Kidney and urinary
    Studied dose
    Dose not stated · 7 hoursAs given in this study (rat).

    Measurements

    Urinary osmolality
    > 300 mOsmol/kg
    PLG group

    Source sentences

    Summary
    Mor, Nal, D-Asp and PLG alone caused a significant decrease in food and fluid intake, urine volume and faeces weight and a significant increase in urinary osmolality being the osmolality of the Mor, D-Asp and PLG injected groups higher than 300 mOsmol/kg.
    2 context sentences
    Summary · context
    Brattleboro rats placed in metabolism cages were injected with morphine (Mor), naloxone (Nal), D- and L-aspartic acid (D- and L-Asp), D-phenylalanine (D-Phe), D-leucine (D-Leu) and prolyl-leucyl-glycinamide (PLG), alone and in suitable combinations.
    Summary · context
    Food and fluid intake, urine outflow, faeces weight, rectal temperature and urinary osmolality were determined at the end of seven hours period of time.

Studies that did not test the peptide alone1

In this study, MIF-1 (Pro-Leu-Gly-NH2) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking MIF-1 (Pro-Leu-Gly-NH2).

  1. 06AnimalNot a test of MIF-1 (Pro-Leu-Gly-NH2) aloneAnimal study (in vivo)Other

    In Brattleboro rats, naloxone appeared to intensify PLG-induced changes, while L-aspartic acid antagonized most changes.

    In plain wordsIn rats, naloxone appeared to strengthen PLG responses, while L-aspartic acid opposed most responses.

    Outcome
    MixedModification of PLG responses
    Study

    ratn: not reported in source

    Brattleboro rats
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The combination of Nal with Mor, D-Asp and PLG appeared to intensify the changes induced by Mor, D-Asp and PLG whereas L-Asp antagonized the majority of changes caused by Mor or PLG.
    2 context sentences
    Summary · context
    Brattleboro rats placed in metabolism cages were injected with morphine (Mor), naloxone (Nal), D- and L-aspartic acid (D- and L-Asp), D-phenylalanine (D-Phe), D-leucine (D-Leu) and prolyl-leucyl-glycinamide (PLG), alone and in suitable combinations.
    Summary · context
    Food and fluid intake, urine outflow, faeces weight, rectal temperature and urinary osmolality were determined at the end of seven hours period of time.

    In this study, MIF-1 (Pro-Leu-Gly-NH2) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MIF-1 (Pro-Leu-Gly-NH2).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.